Drug Target Discovery

The term drug targets regularly used in medicinal research to describe the native protein in the body whose activity is modified by a drug resulting in a distinct effect, which may be a desirable therapeutic effect or an unwanted side effect. In this context, the biological target is often referred to as a biological target. The most common drug targets are G-protein couple receptor, enzymes, ligand gated channels, voltage gated channels, ion channels, nuclear hormone receptor and membrane transport proteins.

 

  • Drug targeting
  • Drug toxicity
  • Drug designing
  • Drug design strategies for targeting g-protein-coupled receptors
  • Biological targets
  • Rational drug design

Related Conference of Drug Target Discovery

November 20-21, 2025

21st Annual Congress on Pharmacology and Toxicology

Paris, France
November 27-28, 2025

4th World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 27-28, 2025

4th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
December 01-02, 2025

13th International Conference on Clinical Trials

Vancouver, Canada
January 29-30, 2026

19th World Drug Delivery Summit

Paris, France
February 10-11, 2026

40th World Congress on Pharmacology and Therapeutics

Barcelona, Spain
February 23-24, 2026

3rd World Congress on Biologics and Biosimilars

London, UK
March 23-24, 2026

36th Annual European Pharma Congress

London, UK
March 24-25, 2026

11th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
April 16-17, 2026

19th European Biosimilars Congress

Rome, Italy
April 27-28, 2026

9th European Biopharma Congress

Paris, Aland Islands
May 28-29, 2026

3rd International Conference on Pharmacognosy

Madrid, Spain
July 27-28, 2026

39th World Congress on Pharmacology

Rome, Italy

Drug Target Discovery Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in